Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of global mortality. Despite advances in primary prevention and acute management, patients with established ASCVD face high residual risks for recurrent major adverse cardiovascular events (MACEs) and chronic kidney disease (CKD) progression. Life’...
Z. Yuan, X. Lu, G. Yuan et al.· European Heart Journal· 0 citations
Higher LE8 scores were associated with lower risks of MACE and CKD in ASCVD patients, and high LE8 achievement may attenuate risks toward non-ASCVD levels.
This study reveals that SRA1 is a novel therapeutic target for PPD, which enhances the understanding of its molecular aetiology and the development of therapeutic strategies.
Ming Chen, Qinlin Wei, Hao-Wen Li et al.· npj Mental Health Research· 0 citations
Findings highlight significant sex differences in the effect of depression on CHD risk, which could inform sex-specific preventive strategies for reducing the cardiovascular burden in individuals with depression.
Haozhang Huang, Ming Chen, Xiao-Zhao Lu et al.· European Journal of Preventi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.